VanEck Associates’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-11,455
Closed -$943K 1415
2022
Q4
$943K Sell
11,455
-327
-3% -$27K ﹤0.01% 818
2022
Q3
$921K Buy
+11,782
New +$942K ﹤0.01% 790

Other funds holding ACHC

VanEck Associates's ACHC Position: Q1 2023 in Review

VanEck Associates sold out of Acadia Healthcare (ACHC) in Q1 2023, closing a stake of 11,455 shares — an estimated $943K sold.

VanEck Associates first reported a position in ACHC in Q3 2022 and held it in 2 quarters. The position peaked at $943K in Q4 2022. 310 funds tracked by Wall St. Rank hold ACHC as of Q1 2023.

  • VanEck Associates reported no remaining Acadia Healthcare position as of Q1 2023 after selling out during the quarter.
  • VanEck Associates sold 11,455 Acadia Healthcare shares in Q1 2023, an estimated $943K.
  • VanEck Associates first reported a position in Acadia Healthcare in Q3 2022 and held it in 2 quarters.
  • VanEck Associates's Acadia Healthcare position peaked at $943K in Q4 2022.
  • 310 funds tracked by Wall St. Rank held Acadia Healthcare as of Q1 2023.

Based on VanEck Associates's 13F filing for Q1 2023, filed 3 May 2023.